Not applicableStudy completedNCT00421304
What this trial is testing
Evaluate a Single Intravenous Dose of Motavizumab for the Treatment of Children Hospitalized With Respiratory Syncytial Virus (RSV) Illness
Who this might be right for
RSV Illness in ≤12 Months of Participants
MedImmune LLC 118